#
GOOD
MORNING
CALCIUM METABOLISM
R . Priya Darshini
1st
year MDS
DEPT OF PROSTHODONTICS
#
CONTENTS
• Introduction
• Calcium
• Dietary requirements
• Sources
• Functions
• Homeostasis of calcium
• Calcitriol
• Parathyroid hormone
• Calcitonin
• Calcium absorption
• Disorders due to Changes in Ca levels
• Investigations of bone and Ca disorders
• Prosthodontic considerations
• Conclusion
#
Introduction
• Mineral (inorganic) elements constitute
only small proportion of body weight.
• Minerals - Principal elements (60-80%)
- Trace elements
• 7 principal elements are Calcium,
Phosphorus, Magnesium, Sodium,
Potassium, Chloride & Sulfur
#
Calcium
• Most abundant mineral in the body.
• Constitutes about 2% of body weight.
• Total content of Ca in adult is 1-1.5kg.
• 99% - bones & teeth.
• 1% - body fluids.
#
Plasma calcium
• Most of the blood Ca is in plasma.
• Normal conc – 9-11 mg/dl.
• 5mg/dl – ionised form – most active.
• 1mg/dl – in association with citrate & P.
• 4-5mg/dl – bound to protien.
• Ionised & citrate bound – diffusible
• Protien bound – non-diffusible.
#
Dietary requirements
• Adult men & women – 800mg/day
• Pregnant, lactating &post menopausal
women – 1.5 g/day.
• Children (1-18yrs) – 0.8-1.2 g/day
• Infants (<1yr) – 300-500 mg/day
#
Sources
• From milk and milk products.
• And also beans, leafy vegetables, fish,
cabbage, egg yolk.
#
Biochemical functions
• Development of bones and teeth
• Muscle contraction
• Blood coagulation
• Nerve transmission
• Membrane integrity and permeability
• Activation of enzymes(lipase, ATPase,
succinate dehydrogenase).
#
• Calcium as intracellular messenger.
Second messanger in liver
glycogenolysis & third messanger for
some hormones like ADH which acts
through cAMP & then Ca.
• Release of hormones (insulin, PTH,
calcitonin)from endocrine glands.
• Acts on myocardium and prolongs
systole.
#
Calcium Homeostasis
#
Homeostasis Of Calcium
• Calcium is almost exclusively present in
blood plasma or serum.
• The hormones Calcitriol, Parathyroid
hormone, Calcitonin are major factors
that regulate plasma calcium
(homeostasis of Ca) within normal
range.
#
Calcitriol
• Active form of vit-D or
1 ,25-
dihydroxycholecalciferol
• Skin-photoactivation of
7-dehydrocholesterol to
cholecalciferol (D3)
Liver-25-
hydroxycholecalciferol –
Kidneys – by 1 –
hydroxylase to 1,25-
dihydroxycholecalciferol
(conversion is mediated
by PTH)
#
FUNCTIONS
 to increase plasma calcium
 increases absorption of Ca in
intestines stimulates formation of
calcium-binding protein in epithelial
cells.
 promotes bone calcification and
deposition by stimulating ca uptake by
osteoblasts.
 inhibits secretion of PTH.
#
Role of Calcitriol
• Stimulates GI absorption of both calcium
and phosphate
• Stimulates renal reabsorption of both
calcium and phosphate
• Stimulates bone resorption
Net effect of calcitriol - ↑ serum calcium
↑ serum
phosphate
#
Parathyroid Hormone
• Parathyroid glands
• Single chain polypeptide -84 AA
• Synthesised as preproPTH –
degraded to proPTH – active PTH
• Formation and secretion of PTH is
promoted by low ca conc.
• Stimulus for secretion of PTH
– low plasma calcium
#
• PTH acts on 3 independent tissues
• Bone – demineralisation by osteoclasts.
this is by PTH stimulated activity of enzymes
pyrophosphate & collagenase which cause
bone resorption. This leads to blood Ca
levels.
• Kidney- PTH Ca reabsorption by kidney
tubules. PTH promotes production of calcitriol
by stimulating 25-hydroxycholecalciferol by 1
hydroxylase.
• Intestine – PTH increases intestinal
absorption of Ca by promoting synthesis of
calcitriol.
#
FUNCTIONS
 to increase plasma calcium
 activation of osteoclasts – stimulates
absorption of Ca, P from bones
 decreases excretion of Ca by kidneys
 increases excretion of P by kidneys
 stimulates conversion of vitamin D to
calcitriol (vitamin D hormon) in kidneys
#
Role of PTH
• Stimulates renal reabsorption of calcium
• Inhibits renal reabsorption of phosphate
• Stimulates bone resorption
• Inhibits bone formation and
mineralization
• Stimulates synthesis of calcitriol
Net effect of PTH - ↑ serum calcium
↓ serum phosphate
#
Calcitonin
• Parafollicular cells of thyroid gland (C-
cells).
• peptide containing 32 amino acids.
• stimulus for secretion – high plasma
calcium.
• Promotes calcification by increasing
activity of osteoblasts.
#
FUNCTIONS
 to decrease plasma calcium and
phosphates
 inhibits osteolysis – decreases
absorption of Ca, P from bones
 stimulates incorporation of Ca, P to
bones
 decreases absorption of Ca, P in
kidneys
 decreases the effect of PTH on bones
– PTH antagonist
#
Calcium Absorption
Absorption of Ca occurs in duodenum by
energy dependent active process.
Factors promoting Ca absorption
1. Vit-D induces synthesis of Ca binding
protein in intestinal epithelial cells &
promotes Ca absorption.
2. PTH – by synthesis of calcitriol.
#
3. Acidity (low pH)
4. Lactose promotes Ca uptake by
intestinal cells.
5. AA Lysine & Arginine.
Factors inhibiting ca absorption
1. Phytates & oxalates by forming
insoluble salts.
2. High content of dietary P results in
formation of insoluble Ca P &prevents
Ca uptake.
#
• Alkaline (high pH)
• High content of dietary fiber interferes
with Ca absorption.
• Free fatty acids react with Ca to form
insoluble Ca soaps.
#
CHANGES IN CA2+
PLASMA LEVEL
Hypocalcemia
• Muscle tetany :
Carpopedal spasm-trousseaus sign
Chvostek’s sign
• Dilatation of heart
• Increased cell membrane permeability
• Impaired blood clotting
• Replacement therapy includes vit-D &
calcium supplements.
#
Dental considerations
• Dental treatment complicated by-
tetany, seizures, psychiatric problems &
learning disability.
• There may be facial parasthesia &facial
twitching caused by tetany (chvostek’s
sign).
• Local anesthesia satiafactory
• Consious sedation after replacement
therapy
#
Hypercalcemia
• Serum calcium level elevated
• Associated with hyperparathyroidism in
which there is serum phosphate and
also alkaline phosphatase activity.
• Diagnosis can be done by determination
of ionised serum calcium level
(elevated to 6-9mg/dl) .
#
Conditions associated:
• Depression of nervous system, reflex
activity.
• Increased heart contractility.
• Lack of appetite & constipation.
• Abdominal pain, peptic ulcers
• Formation of calcium phosphate
crystals(urinary calculi).
• Bone diseases like osteitis fibrosa
cystica.
#
Dental considerations
• Dental treatment complicated by renal
diesease, peptic ulcer & bone frgility.
• LA main means of pain control.
• Conscious sedation with nitrous oxide &
O2.
• General anesthesia complicated b’cos
of cardiovascular complications and
sensitivity to muscle relaxants.
#
Osteoporosis
• Disease – low bone mass and micro-
architectural deterioration of bone
tissue, leading to enhanced bone
fragility and an increase in fracture
risk.
• Most common in advanced age and
also women are more prone b’cos of
loss of estrogen production which
accelarates bone loss.
#
Causes
• Etiology unknown
• May be due to the ability to produce
calcitriol from vitamin-D is decreased
with age.
• Immobilised or sedentary individuals
tend to decrease bone mass.
• Post menopausal, deficiency of
oestrogen has implicated in
development of osteoporosis.
#
Clinical features
• Mild taumatic or non-traumatic injuries
cause fractures
• Chief complications- fracture of neck of
femur, distal radius or humerus, or
vertebral bodies causing gradual
collapse of spine.
• Low back pain.
#
Risk factors
-Increasing age
-Early menopause
-Female sex
-Immobility
-Smoking
-Excess alcohol
-Nutrition(low ca diet,
high protein intake for
long time)
Diseases
Endocrine
-Cushing syndrome
-Hyperparathyroidism
-Hypogonodism
-Acromegaly
-typeI diabetes mellitus
Joint
-Rheumatiod arthritis
Other
-Chronic liver failure
-Chronic renal failure
-Mastocytosis
-Anorexia nervosa
-Inflammatory bowel disease
-Coeliac disease
Drug therapy
-Corticosteroids
-Heparin
-Ciclosporin
-Cytotoxics
#
Investigations
• If fracture is suspected
- plain radiographs.
- bone scintigraphy(pelvis or vertebrae
fracture)
• Bone density – DXA(dual energy x-ray
absorptiometry)
#
Dental considerations
• There seems to be correlation between
osteoporosis and excessive alveolar bone
loss in elderly edentulous patients.
• Jaw osteoporosis is particularly a problem in
women.
• Systematic treatment may improve jaw bone
density.
• There may be risk during general anesthesia,
if there is vertebral collapse and chest
deformities
#
Treatment
• Diet with 1000mg of Ca daily
and 400-800 IU of vit-D.
• 30min of wt bearing
exercises 3 times a week.
• Smoking cessation
• Hormone replacement
therapy.
• Combination therapy of
calcium with vitamin-D.
#
Rickets & Osteomalacia
• Inadequate mineralisation of bone
matrix.
• Usually caused by a defect in vit-D
availability or metabolism.
• In children calcification delayed &
vascularisation impaired.
• In adults osteiod width & delayed
mineralisation assessed by double-
tetracycline labelling.
#
Etiology
Rickets
• In urban areas that were
deprived of sunlight.
• Failure of vit-D synthesis
in skin.(lack of exposure
to sun light).
Osteomalacia
• Postmenopausal women
with history of low dietary
calcium intake and little
exposure to ultra violet
rays.
#
CAUSES
Renal disease
-Chronic renal diesease
-Renal osteodystrophy
-Bone disease due to dialysis
-Tubular disorders
Miscellaneous
-Multiple myeloma
-X-linked hypophosphataemia
-Mesenchymal tumours
Vitamin D deficiency
-Inadequate sunlight exposure
-Low dietary intake
-Malabsorption
coeliac disease
intestinal resection
chronic cholestasis
#
Clinical features
Osteomalacia-
• Remodelling of bone in absence of adequate calcium
– results in softening and distortion of skeleton and
an increased tendency to fracture
• Vague symptoms of bone or muscle pain and
tenderness.
• Fractures rare and asymptomatic.
• Proximal myopathy- waddling gait.
• Occasionally, tetany or other hypocalcemic features.
#
Clinical features
Rickets
• At birth- craniotabes (thin
deformed skull)
• First few years of life- widened
epiphysis at wrists and beading at
costochondral junctions, producing
‘rickety rosary’ or harrison’s sulcus
(groove in mid rib).
• In older children lower limb deformities.
#
Investigations
• Serum alkaline phosphatase –
increased osteoblastic activity
• Plasma calcium – low or normal
raised PTH.
• Serum 25-hydroxyvitamin-D3 low.
• X-rays
• Iliac crest biopsy.
#
Dental considerations
• Dental defects seen in unusally severe
cases, eruption may be retarded.
• Jaws shows abnormal radiolucency.
• Vit-D deficient rickets, skull suture are
wide and frontal bossing present which
are known mostly by dental complaints.
• Teeth – large pulp chambers &
abnormal dentin calcification –liable to
pulpitis and dental abscesses.
#
Treatment
• Increase in dietary vit-D intake and
sunlight exposure.
• Also multiple formulations of vit-D and
its metabolites are available.
• Nutritional deficiency-replacement
doses needed - 400-800 IU daily.
• Gasterectomy malabsorption, liver
disease or hypoparathyroidism – upto
40,000-100,000 IU
#
Investigations of bone and
calcium disorders
• Total plasma calcium (9-11mg/dl)
• PTH & 25-hydroxyvit-D – useful where
hypervitaminosis D or interaction with
antiepileptic drugs is suspected in
hypocalceamia or in hypercalceamia.
• Urinary calcium
(normal-2.5-7.5mmol/24hrs) – increased
when renal tubular resorption of Ca is
decreased or in hypercalceamia.
#
• Markers of bone formation
– Alkaline phosphatase
– Serum osteocalcin
– Type I collagen propeptides
• Markers of bone resorption
-Pyridinoline cross links of collagen
-N-terminal and C-terminal
crosslinked telopeptides
• Diagnostic imaging
-Plain radiographs
-Radionuclide scans
-Magnetic resonance imaging
#
• Bone density measurements
-Conventional radiographs
-Dual energy x-ray absorptiometry
-Quantitative Ctscan
-Quantitative ultrasound
• Bone biopsy
#
Conclusion
• Calcium plays a key role in many physiologic
processes, including contraction of muscles, blood
clotting, transmission of nerve impulse etc.
• 0.1 % of total body calcium is in extracellular fluid,
1% in the cells and rest is stored in bones.
• Many hormones regulate Calcium homeostasis and
any abnormalities in this process could lead to hyper
or hypo calcemic states leading to altered functions
#
Conclusion
• Residual ridge resorption is a primary concern in
edentulous elderly patients and the effects of
hormones and other physical factors should be
remembered when considering prosthodontic
treatment.
#
References
• Hirai T, Ishijima T, Hashkawa Y, Yajima T: Osteoporosis and
reduction of residual ridge in edentulous patients. J Prosthet
Dent. 1993 Jan;69(1):49-56.
• Zmysłowska, Ledzion, Jędrzejewski: Factors affecting
mandibular residual ridge resorption in edentulous patients: a
preliminary report. Folia Morphol. Vol. 66, No. 3, pp. 346–352
• Deshpande s, sarin p: Evaluation of the relationship between
Systemic osteoporosis, dietary ca intake and the reduction of
Residual ridges in an edentulous patient:an in vivo pilot study.
Journal of Clinical and Diagnostic Research. 2009
Aug;7(3):1706-1708.
• Wowern N, Lollerup G: Symptomatic osteoporosis: a risk factor
for residual ridge reduction of the jaws. J Prosthet Dent. 1992
May;67(5):656-60.
#
References
• Shipley, Black CM, Comptson J and O’ Gradaigh:
Rheumatology and bone disease. In: Praveen Kumar, Micheal
Clark (eds) Clinical Medicine, 5th
edition, Saunders, 2002.
• Scully C, Cawson RA: Medical Problems in dentistry, 5th
edition,
Elsevier, 2005.
• Neville, Damm, Allen, Bouquot: Oral and maxillofacial pathology,
2nd
Edition, Elsevier, 2004.
• Shafer, Hine, Levy: A text book of Oral Pathology, 4th
edition, A
prism India edition, 1993.
• Sembulingam K, Sembulingam P: Essentials of medical
physiology, 3rd
edition, Jaypee, 2004.
• Chaudhary: Consise medical physiology.
• Satyanarayana U: Biochemistry, 2nd
edition, Books and allied pvt
ltd, 2002.

CALCIUM METABOLISM.pptx

  • 1.
  • 2.
    CALCIUM METABOLISM R .Priya Darshini 1st year MDS DEPT OF PROSTHODONTICS
  • 3.
    # CONTENTS • Introduction • Calcium •Dietary requirements • Sources • Functions • Homeostasis of calcium • Calcitriol • Parathyroid hormone • Calcitonin • Calcium absorption • Disorders due to Changes in Ca levels • Investigations of bone and Ca disorders • Prosthodontic considerations • Conclusion
  • 4.
    # Introduction • Mineral (inorganic)elements constitute only small proportion of body weight. • Minerals - Principal elements (60-80%) - Trace elements • 7 principal elements are Calcium, Phosphorus, Magnesium, Sodium, Potassium, Chloride & Sulfur
  • 5.
    # Calcium • Most abundantmineral in the body. • Constitutes about 2% of body weight. • Total content of Ca in adult is 1-1.5kg. • 99% - bones & teeth. • 1% - body fluids.
  • 6.
    # Plasma calcium • Mostof the blood Ca is in plasma. • Normal conc – 9-11 mg/dl. • 5mg/dl – ionised form – most active. • 1mg/dl – in association with citrate & P. • 4-5mg/dl – bound to protien. • Ionised & citrate bound – diffusible • Protien bound – non-diffusible.
  • 7.
    # Dietary requirements • Adultmen & women – 800mg/day • Pregnant, lactating &post menopausal women – 1.5 g/day. • Children (1-18yrs) – 0.8-1.2 g/day • Infants (<1yr) – 300-500 mg/day
  • 8.
    # Sources • From milkand milk products. • And also beans, leafy vegetables, fish, cabbage, egg yolk.
  • 9.
    # Biochemical functions • Developmentof bones and teeth • Muscle contraction • Blood coagulation • Nerve transmission • Membrane integrity and permeability • Activation of enzymes(lipase, ATPase, succinate dehydrogenase).
  • 10.
    # • Calcium asintracellular messenger. Second messanger in liver glycogenolysis & third messanger for some hormones like ADH which acts through cAMP & then Ca. • Release of hormones (insulin, PTH, calcitonin)from endocrine glands. • Acts on myocardium and prolongs systole.
  • 11.
  • 12.
    # Homeostasis Of Calcium •Calcium is almost exclusively present in blood plasma or serum. • The hormones Calcitriol, Parathyroid hormone, Calcitonin are major factors that regulate plasma calcium (homeostasis of Ca) within normal range.
  • 13.
    # Calcitriol • Active formof vit-D or 1 ,25- dihydroxycholecalciferol • Skin-photoactivation of 7-dehydrocholesterol to cholecalciferol (D3) Liver-25- hydroxycholecalciferol – Kidneys – by 1 – hydroxylase to 1,25- dihydroxycholecalciferol (conversion is mediated by PTH)
  • 14.
    # FUNCTIONS  to increaseplasma calcium  increases absorption of Ca in intestines stimulates formation of calcium-binding protein in epithelial cells.  promotes bone calcification and deposition by stimulating ca uptake by osteoblasts.  inhibits secretion of PTH.
  • 15.
    # Role of Calcitriol •Stimulates GI absorption of both calcium and phosphate • Stimulates renal reabsorption of both calcium and phosphate • Stimulates bone resorption Net effect of calcitriol - ↑ serum calcium ↑ serum phosphate
  • 16.
    # Parathyroid Hormone • Parathyroidglands • Single chain polypeptide -84 AA • Synthesised as preproPTH – degraded to proPTH – active PTH • Formation and secretion of PTH is promoted by low ca conc. • Stimulus for secretion of PTH – low plasma calcium
  • 17.
    # • PTH actson 3 independent tissues • Bone – demineralisation by osteoclasts. this is by PTH stimulated activity of enzymes pyrophosphate & collagenase which cause bone resorption. This leads to blood Ca levels. • Kidney- PTH Ca reabsorption by kidney tubules. PTH promotes production of calcitriol by stimulating 25-hydroxycholecalciferol by 1 hydroxylase. • Intestine – PTH increases intestinal absorption of Ca by promoting synthesis of calcitriol.
  • 18.
    # FUNCTIONS  to increaseplasma calcium  activation of osteoclasts – stimulates absorption of Ca, P from bones  decreases excretion of Ca by kidneys  increases excretion of P by kidneys  stimulates conversion of vitamin D to calcitriol (vitamin D hormon) in kidneys
  • 19.
    # Role of PTH •Stimulates renal reabsorption of calcium • Inhibits renal reabsorption of phosphate • Stimulates bone resorption • Inhibits bone formation and mineralization • Stimulates synthesis of calcitriol Net effect of PTH - ↑ serum calcium ↓ serum phosphate
  • 20.
    # Calcitonin • Parafollicular cellsof thyroid gland (C- cells). • peptide containing 32 amino acids. • stimulus for secretion – high plasma calcium. • Promotes calcification by increasing activity of osteoblasts.
  • 21.
    # FUNCTIONS  to decreaseplasma calcium and phosphates  inhibits osteolysis – decreases absorption of Ca, P from bones  stimulates incorporation of Ca, P to bones  decreases absorption of Ca, P in kidneys  decreases the effect of PTH on bones – PTH antagonist
  • 22.
    # Calcium Absorption Absorption ofCa occurs in duodenum by energy dependent active process. Factors promoting Ca absorption 1. Vit-D induces synthesis of Ca binding protein in intestinal epithelial cells & promotes Ca absorption. 2. PTH – by synthesis of calcitriol.
  • 23.
    # 3. Acidity (lowpH) 4. Lactose promotes Ca uptake by intestinal cells. 5. AA Lysine & Arginine. Factors inhibiting ca absorption 1. Phytates & oxalates by forming insoluble salts. 2. High content of dietary P results in formation of insoluble Ca P &prevents Ca uptake.
  • 24.
    # • Alkaline (highpH) • High content of dietary fiber interferes with Ca absorption. • Free fatty acids react with Ca to form insoluble Ca soaps.
  • 25.
    # CHANGES IN CA2+ PLASMALEVEL Hypocalcemia • Muscle tetany : Carpopedal spasm-trousseaus sign Chvostek’s sign • Dilatation of heart • Increased cell membrane permeability • Impaired blood clotting • Replacement therapy includes vit-D & calcium supplements.
  • 26.
    # Dental considerations • Dentaltreatment complicated by- tetany, seizures, psychiatric problems & learning disability. • There may be facial parasthesia &facial twitching caused by tetany (chvostek’s sign). • Local anesthesia satiafactory • Consious sedation after replacement therapy
  • 27.
    # Hypercalcemia • Serum calciumlevel elevated • Associated with hyperparathyroidism in which there is serum phosphate and also alkaline phosphatase activity. • Diagnosis can be done by determination of ionised serum calcium level (elevated to 6-9mg/dl) .
  • 28.
    # Conditions associated: • Depressionof nervous system, reflex activity. • Increased heart contractility. • Lack of appetite & constipation. • Abdominal pain, peptic ulcers • Formation of calcium phosphate crystals(urinary calculi). • Bone diseases like osteitis fibrosa cystica.
  • 29.
    # Dental considerations • Dentaltreatment complicated by renal diesease, peptic ulcer & bone frgility. • LA main means of pain control. • Conscious sedation with nitrous oxide & O2. • General anesthesia complicated b’cos of cardiovascular complications and sensitivity to muscle relaxants.
  • 30.
    # Osteoporosis • Disease –low bone mass and micro- architectural deterioration of bone tissue, leading to enhanced bone fragility and an increase in fracture risk. • Most common in advanced age and also women are more prone b’cos of loss of estrogen production which accelarates bone loss.
  • 31.
    # Causes • Etiology unknown •May be due to the ability to produce calcitriol from vitamin-D is decreased with age. • Immobilised or sedentary individuals tend to decrease bone mass. • Post menopausal, deficiency of oestrogen has implicated in development of osteoporosis.
  • 32.
    # Clinical features • Mildtaumatic or non-traumatic injuries cause fractures • Chief complications- fracture of neck of femur, distal radius or humerus, or vertebral bodies causing gradual collapse of spine. • Low back pain.
  • 33.
    # Risk factors -Increasing age -Earlymenopause -Female sex -Immobility -Smoking -Excess alcohol -Nutrition(low ca diet, high protein intake for long time) Diseases Endocrine -Cushing syndrome -Hyperparathyroidism -Hypogonodism -Acromegaly -typeI diabetes mellitus Joint -Rheumatiod arthritis Other -Chronic liver failure -Chronic renal failure -Mastocytosis -Anorexia nervosa -Inflammatory bowel disease -Coeliac disease Drug therapy -Corticosteroids -Heparin -Ciclosporin -Cytotoxics
  • 34.
    # Investigations • If fractureis suspected - plain radiographs. - bone scintigraphy(pelvis or vertebrae fracture) • Bone density – DXA(dual energy x-ray absorptiometry)
  • 35.
    # Dental considerations • Thereseems to be correlation between osteoporosis and excessive alveolar bone loss in elderly edentulous patients. • Jaw osteoporosis is particularly a problem in women. • Systematic treatment may improve jaw bone density. • There may be risk during general anesthesia, if there is vertebral collapse and chest deformities
  • 36.
    # Treatment • Diet with1000mg of Ca daily and 400-800 IU of vit-D. • 30min of wt bearing exercises 3 times a week. • Smoking cessation • Hormone replacement therapy. • Combination therapy of calcium with vitamin-D.
  • 37.
    # Rickets & Osteomalacia •Inadequate mineralisation of bone matrix. • Usually caused by a defect in vit-D availability or metabolism. • In children calcification delayed & vascularisation impaired. • In adults osteiod width & delayed mineralisation assessed by double- tetracycline labelling.
  • 38.
    # Etiology Rickets • In urbanareas that were deprived of sunlight. • Failure of vit-D synthesis in skin.(lack of exposure to sun light). Osteomalacia • Postmenopausal women with history of low dietary calcium intake and little exposure to ultra violet rays.
  • 39.
    # CAUSES Renal disease -Chronic renaldiesease -Renal osteodystrophy -Bone disease due to dialysis -Tubular disorders Miscellaneous -Multiple myeloma -X-linked hypophosphataemia -Mesenchymal tumours Vitamin D deficiency -Inadequate sunlight exposure -Low dietary intake -Malabsorption coeliac disease intestinal resection chronic cholestasis
  • 40.
    # Clinical features Osteomalacia- • Remodellingof bone in absence of adequate calcium – results in softening and distortion of skeleton and an increased tendency to fracture • Vague symptoms of bone or muscle pain and tenderness. • Fractures rare and asymptomatic. • Proximal myopathy- waddling gait. • Occasionally, tetany or other hypocalcemic features.
  • 41.
    # Clinical features Rickets • Atbirth- craniotabes (thin deformed skull) • First few years of life- widened epiphysis at wrists and beading at costochondral junctions, producing ‘rickety rosary’ or harrison’s sulcus (groove in mid rib). • In older children lower limb deformities.
  • 42.
    # Investigations • Serum alkalinephosphatase – increased osteoblastic activity • Plasma calcium – low or normal raised PTH. • Serum 25-hydroxyvitamin-D3 low. • X-rays • Iliac crest biopsy.
  • 43.
    # Dental considerations • Dentaldefects seen in unusally severe cases, eruption may be retarded. • Jaws shows abnormal radiolucency. • Vit-D deficient rickets, skull suture are wide and frontal bossing present which are known mostly by dental complaints. • Teeth – large pulp chambers & abnormal dentin calcification –liable to pulpitis and dental abscesses.
  • 44.
    # Treatment • Increase indietary vit-D intake and sunlight exposure. • Also multiple formulations of vit-D and its metabolites are available. • Nutritional deficiency-replacement doses needed - 400-800 IU daily. • Gasterectomy malabsorption, liver disease or hypoparathyroidism – upto 40,000-100,000 IU
  • 45.
    # Investigations of boneand calcium disorders • Total plasma calcium (9-11mg/dl) • PTH & 25-hydroxyvit-D – useful where hypervitaminosis D or interaction with antiepileptic drugs is suspected in hypocalceamia or in hypercalceamia. • Urinary calcium (normal-2.5-7.5mmol/24hrs) – increased when renal tubular resorption of Ca is decreased or in hypercalceamia.
  • 46.
    # • Markers ofbone formation – Alkaline phosphatase – Serum osteocalcin – Type I collagen propeptides • Markers of bone resorption -Pyridinoline cross links of collagen -N-terminal and C-terminal crosslinked telopeptides • Diagnostic imaging -Plain radiographs -Radionuclide scans -Magnetic resonance imaging
  • 47.
    # • Bone densitymeasurements -Conventional radiographs -Dual energy x-ray absorptiometry -Quantitative Ctscan -Quantitative ultrasound • Bone biopsy
  • 48.
    # Conclusion • Calcium playsa key role in many physiologic processes, including contraction of muscles, blood clotting, transmission of nerve impulse etc. • 0.1 % of total body calcium is in extracellular fluid, 1% in the cells and rest is stored in bones. • Many hormones regulate Calcium homeostasis and any abnormalities in this process could lead to hyper or hypo calcemic states leading to altered functions
  • 49.
    # Conclusion • Residual ridgeresorption is a primary concern in edentulous elderly patients and the effects of hormones and other physical factors should be remembered when considering prosthodontic treatment.
  • 50.
    # References • Hirai T,Ishijima T, Hashkawa Y, Yajima T: Osteoporosis and reduction of residual ridge in edentulous patients. J Prosthet Dent. 1993 Jan;69(1):49-56. • Zmysłowska, Ledzion, Jędrzejewski: Factors affecting mandibular residual ridge resorption in edentulous patients: a preliminary report. Folia Morphol. Vol. 66, No. 3, pp. 346–352 • Deshpande s, sarin p: Evaluation of the relationship between Systemic osteoporosis, dietary ca intake and the reduction of Residual ridges in an edentulous patient:an in vivo pilot study. Journal of Clinical and Diagnostic Research. 2009 Aug;7(3):1706-1708. • Wowern N, Lollerup G: Symptomatic osteoporosis: a risk factor for residual ridge reduction of the jaws. J Prosthet Dent. 1992 May;67(5):656-60.
  • 51.
    # References • Shipley, BlackCM, Comptson J and O’ Gradaigh: Rheumatology and bone disease. In: Praveen Kumar, Micheal Clark (eds) Clinical Medicine, 5th edition, Saunders, 2002. • Scully C, Cawson RA: Medical Problems in dentistry, 5th edition, Elsevier, 2005. • Neville, Damm, Allen, Bouquot: Oral and maxillofacial pathology, 2nd Edition, Elsevier, 2004. • Shafer, Hine, Levy: A text book of Oral Pathology, 4th edition, A prism India edition, 1993. • Sembulingam K, Sembulingam P: Essentials of medical physiology, 3rd edition, Jaypee, 2004. • Chaudhary: Consise medical physiology. • Satyanarayana U: Biochemistry, 2nd edition, Books and allied pvt ltd, 2002.